GOLDMAN SACHS GROUP INC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$15,306,143
-59.0%
371,058
-44.5%
0.00%
-62.5%
Q2 2023$37,330,660
+73.8%
668,529
+73.6%
0.01%
+60.0%
Q1 2023$21,484,561
-56.5%
385,097
-71.6%
0.01%
-54.5%
Q4 2022$49,423,317
+236.5%
1,356,293
+163.0%
0.01%
+266.7%
Q3 2022$14,686,000
-49.4%
515,686
-19.6%
0.00%
-57.1%
Q2 2022$29,024,000
-44.4%
641,418
-6.5%
0.01%
-36.4%
Q1 2022$52,204,000
+75.0%
686,270
+242.7%
0.01%
+83.3%
Q4 2021$29,833,000
-6.4%
200,273
-8.5%
0.01%
-14.3%
Q3 2021$31,862,000
-69.7%
218,862
-59.2%
0.01%
-70.8%
Q2 2021$105,054,000
+12.5%
536,481
+4.0%
0.02%
+4.3%
Q1 2021$93,405,000
+65.5%
516,045
+29.5%
0.02%
+53.3%
Q4 2020$56,446,000
+12.6%
398,626
-0.8%
0.02%
+7.1%
Q3 2020$50,126,000
+56.1%
402,034
+11.8%
0.01%
+40.0%
Q2 2020$32,118,000
+184.5%
359,623
+98.5%
0.01%
+150.0%
Q1 2020$11,289,000
+49.0%
181,154
+82.3%
0.00%
+100.0%
Q4 2019$7,576,000
+5.8%
99,356
-30.1%
0.00%0.0%
Q3 2019$7,164,000142,1460.00%
Other shareholders
10X GENOMICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,358,528$49,504,760100.00%
Meritech Capital Associates V L.L.C. 1,061,682$38,687,6929.44%
Decheng Capital Management III (Cayman), LLC 359,554$13,102,1484.90%
Sands Capital Ventures, LLC 481,770$17,5564.81%
Whitford Management LLC 58,310$2,124,8032.88%
FINANCIAL CONSULATE, INC 156,457$5,701,2931.99%
SRS Investment Management, LLC 3,005,427$109,517,7601.98%
BRANDYWINE MANAGERS, LLC 11,208$408,4201.43%
ARK Investment Management 4,316,567$157,295,7011.36%
Nikko Asset Management Americas, Inc. 2,177,988$79,365,8831.14%
View complete list of 10X GENOMICS INC shareholders